Evidence map›Paper›PMID 33601113›Full record

ArticleVirology2021

Rat and human cytomegalovirus ORF116 encodes a virion envelope glycoprotein required for infectivity.

Philippe Gatault, Iris K A Jones, Christine Meyer, Craig Kreklywich, Timothy Alexander, Patricia P Smith, Michael Denton, Josh Powell, Susan L Orloff, Daniel N Streblow

Open access · greenAbstract read
In one paragraph

Article in Virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Philippe GataultRenal Transplant Unit, 10 Boulevard Tonnellé, University Hospital of Tours, France.
Iris K A JonesVaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Christine MeyerVaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Craig KreklywichVaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Timothy AlexanderVaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Patricia P SmithVaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Michael DentonVaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Josh PowellVaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Susan L OrloffDepartment of Surgery, Oregon Health & Science University, Portland, OR, 97239, USA.
Daniel N StreblowVaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA. Electronic address: streblow@ohsu.edu.
Oregon Health & Science University · USUniversité de Tours · FR

Funding

The Administrative CoreP01AI127335 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI DANIEL N STREBLOW, ANDREW D YUROCHKO · 2017 to 2026
$24.6M
INTERACTIONS AT THE MICROBE/HOST INTERFACET32AI007472 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LANDFEAR, SCOTT M · 1995 to 2019
$6.7M
Characterizing the Role of CMV Latency in Solid Organ Transplant RejectionR01AI116633 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI STREBLOW, DANIEL N · 2016 to 2020
$1.8M
Characterizing the Role of CMV Latency in Solid Organ Transplant RejectionR56AI116633 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI STREBLOW, DANIEL N · 2015 to 2015
$438k
The Effects of Cytomegalovirus on Organ Transplant RejectionF31AI145193 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI JONES, IRIS KATHERINE ARCHER · 2019 to 2020
$72k
NIAID NIH HHS F31 AI145193NIAID NIH HHS P01 AI127335NIAID NIH HHS R01 AI116633NIAID NIH HHS R56 AI116633NIAID NIH HHS T32 AI007472
6 · The paper itself

Abstract

Herpesviruses encode multiple glycoproteins required for different stages of viral attachment, fusion, and envelopment. The protein encoded by the human cytomegalovirus (HCMV) open reading frame UL116 forms a stable complex with glycoprotein H that is incorporated into virions. However, the function of this complex remains unknown. Herein, we characterize R116, the rat CMV (RCMV) putative homolog of UL116. Two R116 transcripts were identified in fibroblasts with three proteins expressed with molecular weights of 42, 58, and 82 kDa. R116 is N-glycosylated, expressed with late viral gene kinetics, and is incorporated into the virion envelope. RCMV lacking R116 failed to result in productive infection of fibroblasts and siRNA knockdown of R116 substantially reduced RCMV infectivity. Complementation in trans of an R116-deficient virus restored ability of the virus to infect fibroblasts. Finally, UL116 knockdown also decreased HCMV infectivity indicating that R116 and UL116 both contribute to viral infectivity.

Indexed as

AnimalsCytomegalovirusFibroblastsGlycosylationHumansOpen Reading FramesRatsRNA, Double-StrandedViral Envelope ProteinsVirionVirus AttachmentVirus InternalizationRNA, Double-StrandedViral Envelope ProteinsCytomegalovirusGlycoproteinsViral entry

Identifiers

PMID33601113
PMCPMC8019331
OpenAlexW3128065455

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.